SIRT1 and cancer: Accordingly, this context-dependent role of SIRT1 represents a target for selective killing of cancer versus non-cancer cells [123], and a recent drug screening approach has led to the identification of a potent SIRT1/2 inhibitory substance with potential use in cancer therapy [124].